Effectiveness and Safety of Concurrent Beta-Blockers and Inhaled Bronchodilators in COPD With Cardiovascular Comorbidities

European Respiratory Review - United Kingdom
doi 10.1183/16000617.0123-2016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids

Journal of the American Medical Directors Association
MedicineHealth PolicyGerontologyGeriatricsNursing
2019English

A Study on the Cardiovascular Comorbidities in COPD Patients

Journal of Medical Science And clinical Research
2018English

New Bronchodilators and Combinations in COPD Treatment

Tuberkuloz ve Toraks
PulmonaryCritical CareRespiratory MedicineSurgeryIntensive Care Medicine
2016English

Angiotensin Receptor Blockers: Rational Prescription Tailored to the Cardiovascular Risk and Comorbidities

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2018English

Cardiovascular Comorbidities in Hospitalised COPD Patients: A Determinant of Future Risk?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2015English

Heart Rate and Cardiovascular Disease: An Alternative to Beta Blockers

Cardiology Research and Practice
Cardiovascular MedicineCardiology
2009English

Inhaled Beta-2-Agonists/Muscarinic Antagonists and Acute Myocardial Infarction in COPD Patients

Respiratory Medicine
PulmonaryRespiratory Medicine
2014English

Overtreatment of COPD With Inhaled Corticosteroids - Implications for Safety and Costs: Cross-Sectional Observational Study

PLoS ONE
Multidisciplinary
2013English

Systemic Manifestations and Comorbidities of COPD

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy